Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 22.31
+0.58 (2.67%)
Jul 21, 2026, 3:05 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 19.19 billion as of July 20, 2026. Its market cap has increased by 12.71% in one year.
Market Cap
19.19B
Enterprise Value
21.06B
Revenue
955.53M
Ranking
n/a
PE Ratio
212.47
Stock Price
22.31
ChartMarket Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 19.19B, an increase of 555.05%. That is a compound annual growth rate of 13.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 19.19B | 21.40% |
| Dec 31, 2025 | 15.81B | 38.87% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apeloa Pharmaceutical Co.,Ltd | 22.12B |
| Jilin Aodong Pharmaceutical Group | 21.17B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.03B |
| Walvax Biotechnology | 20.47B |
| Chengdu Kanghong Pharmaceutical Group | 20.31B |
| Kangmei Pharmaceutical | 18.67B |
| Joincare Pharmaceutical Group Industry | 18.31B |
| China Resources Double-Crane Pharmaceutical | 17.49B |